Hamilton Capital Partners (Canada)’s AbbVie ABBV Stock Holding History

Hamilton Capital Partners (Canada)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.21M	Buy	36,591 +5,366	+17%	+$1.15M	0.27%	72
2026 Q1	$6.79M	Buy	31,225 +6,818	+28%	+$1.51M	0.23%	68
2025 Q4	$5.58M	Buy	24,407 +3,267	+15%	+$744K	0.2%	90
2025 Q3	$4.89M	Sell	21,140 -3,218	-13%	-$655K	0.2%	87
2025 Q2	$4.52M	Buy	24,358 +4,877	+25%	+$906K	0.23%	87
2025 Q1	$4.08M	Sell	19,481 -579	-3%	-$113K	0.26%	81
2024 Q4	$3.56M	Sell	20,060 -2,516	-11%	-$463K	0.27%	79
2024 Q3	$4.46M	Sell	22,576 -3,869	-15%	-$722K	0.39%	60
2024 Q2	$4.54M	Buy	26,445 +1,486	+6%	+$246K	0.49%	64
2024 Q1	$4.55M	Buy	+24,959	New	+$4.3M	0.55%	60

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hamilton Capital Partners (Canada)'s ABBV Position: Q2 2026 in Review

Hamilton Capital Partners (Canada) increased its AbbVie (ABBV) stake by 17% in Q2 2026, buying an estimated $1.15M and bringing the position to 36,591 shares worth $9.21M. The position accounts for 0.27% of the portfolio, ranked #72.

Hamilton Capital Partners (Canada) first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Hamilton Capital Partners (Canada) held 36,591 shares of AbbVie worth $9.21M as of Q2 2026.
Hamilton Capital Partners (Canada) bought 5,366 AbbVie shares in Q2 2026, an estimated $1.15M.
AbbVie made up 0.27% of Hamilton Capital Partners (Canada)'s portfolio in Q2 2026, its #72 holding.
Hamilton Capital Partners (Canada) first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hamilton Capital Partners (Canada)'s 13F filing for Q2 2026, filed 14 Aug 2026.